2.44
前日終値:
$2.51
開ける:
$2.48
24時間の取引高:
1.62M
Relative Volume:
0.67
時価総額:
$204.26M
収益:
$32.31M
当期純損益:
$-237.09M
株価収益率:
-0.8472
EPS:
-2.88
ネットキャッシュフロー:
$-219.11M
1週間 パフォーマンス:
-22.54%
1か月 パフォーマンス:
+8.44%
6か月 パフォーマンス:
+86.26%
1年 パフォーマンス:
-52.53%
Editas Medicine Inc Stock (EDIT) Company Profile
EDIT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
EDIT
Editas Medicine Inc
|
2.44 | 210.12M | 32.31M | -237.09M | -219.11M | -2.88 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Editas Medicine Inc Stock (EDIT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-28 | 開始されました | H.C. Wainwright | Buy |
2024-12-16 | ダウングレード | JP Morgan | Neutral → Underweight |
2024-12-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
2024-12-13 | ダウングレード | Stifel | Buy → Hold |
2024-12-13 | ダウングレード | Truist | Buy → Hold |
2024-12-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2024-11-25 | ダウングレード | BofA Securities | Buy → Underperform |
2024-11-06 | アップグレード | Evercore ISI | In-line → Outperform |
2024-11-04 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2024-08-08 | アップグレード | BofA Securities | Neutral → Buy |
2024-05-09 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
2023-10-24 | アップグレード | Citigroup | Neutral → Buy |
2023-10-18 | アップグレード | JP Morgan | Underweight → Neutral |
2023-10-17 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2023-09-29 | アップグレード | Stifel | Hold → Buy |
2023-06-12 | アップグレード | Raymond James | Mkt Perform → Outperform |
2023-02-01 | 開始されました | Cantor Fitzgerald | Overweight |
2022-12-13 | 開始されました | Citigroup | Neutral |
2022-12-06 | 再開されました | Credit Suisse | Neutral |
2022-11-18 | ダウングレード | Credit Suisse | Outperform → Neutral |
2022-11-18 | ダウングレード | Oppenheimer | Outperform → Perform |
2022-09-29 | 開始されました | BofA Securities | Neutral |
2021-10-19 | 開始されました | SVB Leerink | Mkt Perform |
2021-09-24 | 開始されました | Stifel | Hold |
2021-09-10 | アップグレード | Oppenheimer | Perform → Outperform |
2021-08-09 | アップグレード | Truist | Hold → Buy |
2021-08-05 | アップグレード | Evercore ISI | Underperform → Outperform |
2021-06-04 | 再開されました | Robert W. Baird | Outperform |
2021-05-04 | 開始されました | RBC Capital Mkts | Sector Perform |
2021-04-16 | 開始されました | Goldman | Sell |
2021-03-22 | 開始されました | Credit Suisse | Outperform |
2021-03-01 | ダウングレード | Barclays | Overweight → Equal Weight |
2021-02-26 | ダウングレード | Truist | Buy → Hold |
2021-01-19 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2021-01-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2020-12-10 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2020-11-03 | 開始されました | Robert W. Baird | Underperform |
2020-06-18 | 再開されました | SunTrust | Buy |
2020-02-21 | 開始されました | Wells Fargo | Equal Weight |
2019-04-12 | 開始されました | Evercore ISI | Outperform |
2018-10-10 | 開始されました | Guggenheim | Neutral |
2018-09-21 | 開始されました | Raymond James | Outperform |
2018-05-15 | 繰り返されました | Chardan Capital Markets | Buy |
2018-02-13 | 開始されました | CLSA | Underperform |
2018-01-23 | アップグレード | SunTrust | Hold → Buy |
2017-07-14 | 開始されました | SunTrust | Hold |
2017-03-28 | 開始されました | Chardan Capital Markets | Buy |
2016-08-10 | アップグレード | Jefferies | Hold → Buy |
2016-06-02 | 開始されました | Jefferies | Hold |
2016-02-29 | 開始されました | JMP Securities | Mkt Outperform |
2016-02-29 | 開始されました | JP Morgan | Neutral |
2016-02-29 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Editas Medicine Inc (EDIT) 最新ニュース
Is Editas Medicine Inc. a growth stock or a value stockPre Market Picks With High Returns - jammulinksnews.com
What are analysts’ price targets for Editas Medicine Inc. in the next 12 monthsReal Time Watchlist To Watch Now - jammulinksnews.com
What is the dividend policy of Editas Medicine Inc. stockTop Growth Alerts With Proven Results - jammulinksnews.com
Are Medical Stocks Lagging Editas Medicine (EDIT) This Year? - Yahoo Finance
Editas Medicine (EDIT) Expected to Announce Earnings on Wednesday - MarketBeat
Editas MedicinePrimed For An Unlikely Comeback? It's Not Impossible - Seeking Alpha
EDIT SEC FilingsEditas Medicine Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Editas Medicine Inc. Flashes Buy Signal on Multi Timeframe ChartChart Driven High Reward Trading Setup Presented - metal.it
Published on: 2025-07-29 18:14:10 - metal.it
Published on: 2025-07-29 11:06:01 - metal.it
Editas Medicine (NASDAQ:EDIT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Gene Editing Market Exclusive Report with Detailed Study - openPR.com
What is Editas Medicine Inc. company’s growth strategyFree Stock Index Interpretation - jammulinksnews.com
Does Editas Medicine Inc. stock perform well during market downturnsHigh-velocity capital appreciation - jammulinksnews.com
Why is Editas Medicine Inc. stock attracting strong analyst attentionMaximize returns with smart investment plans - jammulinksnews.com
What catalysts could drive Editas Medicine Inc. stock higher in 2025Invest confidently with daily market forecasts - jammulinksnews.com
Should I hold or sell Editas Medicine Inc. stock in 2025Identify breakout stocks before they peak - jammulinksnews.com
Is Editas Medicine Inc. stock overvalued or undervaluedUnlock daily market insights for better decisions - jammulinksnews.com
What drives Editas Medicine Inc. stock priceTriple-digit profit margins - PrintWeekIndia
Will Editas Medicine Inc. stock split in the near futureConsistent triple-digit returns - jammulinksnews.com
Can Editas Medicine Inc. stock recover from recent declineFree Stock Market Forecast Reports - jammulinksnews.com
What analysts say about Editas Medicine Inc. stockBreakout stock performance - Autocar Professional
What drives Avanos Medical Inc. stock priceExplosive market performance - jammulinksnews.com
Editas Medicine Inc. Stock Analysis and ForecastUnrivaled growth potential - jammulinksnews.com
Is Editas Medicine Inc. a good long term investmentExceptional profit margins - Autocar Professional
There's Reason For Concern Over Editas Medicine, Inc.'s (NASDAQ:EDIT) Massive 42% Price Jump - simplywall.st
What makes Editas Medicine Inc. stock price move sharplyVerified Return Tips - beatles.ru
Editas Medicine Inc (EDIT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):